Betsy LaPlant

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations”.

High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations

Blood(2024)10.1182/blood.2024024962

N/A

0.472DataRank · unranked

13 citations

Jenna Fernandez, Terra L. Lasho, Christy M. Finke, Michelle Amundson, Kristen McCullough +8 more

Relevance of bone marrow biopsies for response assessment in NCTN follicular lymphoma clinical trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8038

N/A

0DataRank · unranked

1 citations

Jun Yin, Levi Pederson, Betsy LaPlant, Mazyar Shadman, Hongli Li +15 more

Effect of antibiotic use prior to or concurrent with immune checkpoint inhibitors on outcomes in patients with Hodgkin lymphoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8030

N/A

0DataRank · unranked

0 citations

Alexandra Higgins, Betsy LaPlant, Matthew J. Maurer, Stephen M. Ansell, Gita Thanarajasingam +2 more

Prevalence and significance of clonal hematopoiesis of indeterminate prognosis (CHIP) in multiple myeloma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8542

N/A

0DataRank · unranked

2 citations

Betsy LaPlant, Shaji Kumar, Kimbery Henderson, Angela Dispenzieri, Terra L. Lasho +3 more

Alemtuzumab in frontline therapy of adult acute lymphoblastic leukemia: Results of Cancer and Leukemia Group B 10102 (Alliance), a phase 1/2 study

Cancer(2025)10.1002/cncr.35750

N/A

0DataRank · unranked

3 citations

Jun Yin, Gerard Lozanski, Emily Curran, Gregory Malnassy, Krzysztof Mrózek +15 more

Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408

Blood Neoplasia(2025)10.1016/j.bneo.2025.100113

N/A

0DataRank · unranked

1 citations

Stephen M. Broski, Zequn Sun, Masha Kocherginsky, Betsy LaPlant, Matthew J. Maurer +10 more

Phase II trial assessing safety and preliminary efficacy of high-dose intravenous ascorbic acid in patients with TET2-mutant clonal cytopenias of undetermined significance.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps7076

N/A

0DataRank · unranked

3 citations

Terra L. Lasho, Jenna Fernandez, Christy M. Finke, Michelle Amundson, Betsy LaPlant +4 more